<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR17">
 <label>17.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Xia</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Lan</surname>
    <given-names>Q</given-names>
   </name>
   <name>
    <surname>Feng</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Qi</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Bao</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Du</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Qin</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Shi</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Jiang</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Lu</surname>
    <given-names>L</given-names>
   </name>
  </person-group>
  <article-title>Inhibition of SARS-CoV-2 (previously 2019-nCoV)Â infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion</article-title>
  <source>Cell Res</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1038/s41422-020-0305-x</pub-id>
  <?supplied-pmid 32801356?>
  <pub-id pub-id-type="pmid">32801356</pub-id>
 </element-citation>
</ref>
